Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Harvard Apparatus Regenerative Technology Inc. currently maintains 1 pending office action within the Medical Devices & Mechanical Engineering technology area. This prosecution activity is confined to 1 distinct art unit and is being handled by 1 distinct examiner. The specific examiner assigned to this case is GANESAN, SUBA.
GANESAN, SUBA is the busiest examiner for the portfolio, holding 1 pending office action. This concentration of 1 pending office action under a single examiner in 1 distinct art unit indicates a focused approach to patent acquisition in the Medical Devices & Mechanical Engineering sector. There is no distribution of work across multiple units or examiners at this stage.
For the practitioner, this means that the immediate future of the company's patent prosecution depends on the review of this 1 pending office action. The singular nature of the 1 distinct examiner and 1 distinct art unit allows for a very specific preparation for interviews or responses. Success in this technology area is currently channeled through this single active matter, requiring a high degree of precision in the upcoming prosecution steps.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §102 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GANESAN, SUBA | 1 | 73.8% | +13.4% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18228828 | SYSTEMS AND METHODS FOR MINIMIZING FIBROTIC SCAR FORMATION SUBSEQUENT TO TRAUMA IN TUBULAR ORGANS | GANESAN, SUBA | — |
| Art Unit | Apps |
|---|---|
| 3774 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18228828 | SYSTEMS AND METHODS FOR MINIMIZING FIBROTIC SCAR FORMATION SUBSEQUENT TO TRAUMA IN TUBULAR ORGANS | GANESAN, SUBA | 3774 | §102 | Non-Final OA | — | Pending | Aug 01, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialHarvard Apparatus Regenerative Technology Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Suba Ganesan has the most, with 1 of Harvard Apparatus Regenerative Technology Inc.'s pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
